
"We completed this transition in 2019-20 and started witnessing an uptick in performance in the last quarter of the fiscal," Alembic Pharmaceuticals Managing Directors Pranav Amin and Shaunak Amin said in a joint communication.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OdhzMG
via
IFTTT
0 comments:
Post a Comment